CETP inhibitor, Anacetrapib, Purity ≥98%

Synonym: 875446-37-0; MK0859; MK 0859; MK-0859; (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one; CETP inhibitor

MDL: MFCD16294903
CAS Number: 875446-37-0
Compound CID: 11556427

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Anacetrapib, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting CETP. The molecular weight of the compound is 637.5, and its molecular formula is C₃₀H₂₅F₁₀NO₃.

Molecular Weight

637.5

Molecular Formula

C₃₀H₂₅F₁₀NO₃

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 108 mg/mL (169.41 mM); Water: insoluble; Ethanol: 108 mg/mL (169.41 mM); In vivo: 30% PEG400 + 0.5% Tween80 + 5% propylene glycol, 9 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Anacetrapib can be used for its potential to raise high-density lipoprotein (HDL) cholesterol levels and reduce low-density lipoprotein (LDL) cholesterol levels, which could benefit cardiovascular health by lowering the risk of heart disease.